Classification and Regression Tree (CART) analysis to predict influenza in primary care patients

BMC Infectious Diseases

Volumn 16, Issue 1, 2016, Pages

  Zimmerman, Richard K ^a,g   Balasubramani, G K ^a   Nowalk, Mary Patricia ^a   Eng, Heather ^a   Urbanski, Leonard ^h   Jackson, Michael L ^e   Jackson, Lisa A ^e   McLean, Huong Q ^b   Belongia, Edward A ^b   Monto, Arnold S ^f   Malosh, Ryan E ^f   Gaglani, Manjusha ^d   Clipper, Lydia ^d   Flannery, Brendan ^c   Wisniewski, Stephen R ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b MARSHFIELD CLINIC   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d TEXAS A M COLLEGE OF MEDICINE   (United States)

^e CENTER FOR HEALTH STUDIES   (United States)

^f UNIVERSITY OF MICHIGAN   (United States)

^g UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Clinical decision tools; Influenza; Recursive partitioning

Indexed keywords

ANTIVIRUS AGENT;

ADULT; ALGORITHM; ARTICLE; CLASSIFICATION AND REGRESSION TREE; COUGHING; DIAGNOSTIC TEST ACCURACY STUDY; FATIGUE; FEVER; HUMAN; INFLUENZA; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PRIMARY MEDICAL CARE; PROBABILITY; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; STATISTICAL MODEL;

EID: 84995551117     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-016-1839-x     Document Type: Article

References (29)

1. Thompson WW, Shay DK, Weintraub E, Brammer L, Bridges CB, Cox NJ, Fukuda K. Influenza-associated hospitalizations in the United States. JAMA. 2004;292(11):1333-40.
2. Molinari NA, Ortega-Sanchez IR, Messonnier ML, Thompson WW, Wortley PM, Weintraub E, Bridges CB. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine. 2007;25(27):5086-96.
3. Heneghan CJ, Onakpoya I, Jones MA, Doshi P, Del Mar CB, Hama R, Thompson MJ, Spencer EA, Mahtani KR, Nunan D, et al. Neuraminidase inhibitors for influenza: a systematic review and meta-analysis of regulatory and mortality data. Health Technol Assess. 2016;20(42):1-242.
4. Jefferson T, Jones MA, Doshi P, Del Mar CB, Hama R, Thompson MJ, Spencer EA, Onakpoya I, Mahtani KR, Nunan D, et al. Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database Syst Rev. 2014;4, CD008965.
5. Fiore AE, Fry A, Shay D, Gubareva L, Bresee JS, Uyeki TM. Antiviral agents for the treatment and chemoprophylaxis of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). Recommendations and Reports. MMWR. 2011;60(RR01);1-24.
6. Dobson J, Whitley RJ, Pocock S, Monto AS. Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials. Lancet. 2015;385(9979):1729-37.
7. Hernan MA, Lipsitch M. Oseltamivir and risk of lower respiratory tract complications in patients with flu symptoms: a meta-analysis of eleven randomized clinical trials. Clin Infect Dis. 2011;53(3):277-9.
8. Hsu J, Santesso N, Mustafa R, Brozek J, Chen YL, Hopkins JP, Cheung A, Hovhannisyan G, Ivanova L, Flottorp SA, et al. Antivirals for treatment of influenza: a systematic review and meta-analysis of observational studies. Ann Intern Med. 2012;156(7):512-24.
9. Havers F, Thaker S, Clippard JR, Jackson M, McLean HQ, Gaglani M, Monto AS, Zimmerman RK, Jackson L, Petrie JG, et al. Use of Influenza Antiviral Agents by Ambulatory Care Clinicians During the 2012-2013 Influenza Season. Clin Infect Dis. 2015;60(11):1677-80.
10. Rapid Diagnostic Testing for Influenza: Information for Clinical Laboratory Directors http://www.cdc.gov/flu/professionals/diagnosis/rapidlab.htm. Accessed 6 June 2016.
11. Bright T, Wong A, Dhurjati R, Bristow E, Bastian L, Coeytaux R, Samsa G, Hasselblad V, Williams J, Musty M, et al. Effect of clinical decision-support systems: a systematic review. Ann Intern Med. 2012;157(1):29-43.
12. Patel RB, Mathur MB, Gould M, Uyeki TM, Bhattacharya J, Xiao Y, Khazeni N. Demographic and clinical predictors of mortality from highly pathogenic avian influenza A (H5N1) virus infection: CART analysis of international cases. PLoS One. 2014;9(3), e91630.
13. Ebell MH, Afonso AM, Gonzales R, Stein J, Genton B, Senn N. Development and validation of a clinical decision rule for the diagnosis of influenza. J Am Board Fam Med. 2012;25(1):55-62.
14. Afonso AM, Ebell MH, Gonzales R, Stein J, Genton B, Senn N. The use of classification and regression trees to predict the likelihood of seasonal influenza. Fam Pract. 2012;29(6):671-7.
15. Breiman L, Friedman JH, Olshen RA, Stone CJ. Classification and regression trees (Wadsworth statistics/probability). Boca Raton: Chapman & Hall; 1984.
16. Ohmit SE, Thompson MG, Petrie JG, Thaker SN, Jackson ML, Belongia EA, Zimmerman RK, Gaglani M, Lamerato L, Spencer SM, et al. Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates. Clin Infect Dis. 2014;58(3):319-27.
17. Spencer S, Gaglani M, Naleway A, Reynolds S, Ball S, Bozeman S, Henkle E, Meece J, Vandermause M, Clipper L, et al. Consistency of influenza A virus detection test results across respiratory specimen collection methods using real-time reverse transcription-PCR. J Clin Microbiol. 2013;51(11):3880-2.
18. Jackson ML, Nelson JC. The test-negative design for estimating influenza vaccine effectiveness. Vaccine. 2013;31(17):2165-8.
19. Foppa IM, Haber M, Ferdinands JM, Shay DK. The case test-negative design for studies of the effectiveness of influenza vaccine. Vaccine. 2013;31(30):3104-9.
20. De Serres G, Skowronski DM, Wu XW, Ambrose CS. The test-negative design: validity, accuracy and precision of vaccine efficacy estimates compared to the gold standard of randomised placebo-controlled clinical trials. Euro Surveillance 2013; 18(37).
21. Monto AS, Gravenstein S, Elliott M, Colopy M, Schweinle J. Clinical signs and symptoms predicting influenza infection. Arch Intern Med. 2000;160(21):3243-7.
22. Stein J, Louie J, Flanders S, Maselli J, Hacker JK, Drew WL, Gonzales R. Performance characteristics of clinical diagnosis, a clinical decision rule, and a rapid influenza test in the detection of influenza infection in a community sample of adults. Ann Emerg Med. 2005;46(5):412-9.
23. Ohmit SE, Monto AS. Symptomatic predictors of influenza virus positivity in children during the influenza season. Clin Infect Dis. 2006;43(5):564-8.
24. Ebell MH, Afonso A. A systematic review of clinical decision rules for the diagnosis of influenza. Ann Fam Med. 2011;9(1):69-77.
25. Pauker SG, Kassirer JP. The threshold approach to clinical decision making. N Engl J Med. 1980;302(20):1109-17.
26. Ebell MH, Locatelli I, Senn N. A novel approach to the determination of clinical decision thresholds. Evid Based Med. 2015.
27. Havers FP, Flannery B, Clippard JR, Gaglani M, Zimmerman RK, Jackson LA, Petrie JG, McLean HQ, Nowalk MP, Jackson ML, et al. Use of influenza antiviral medications among outpatients at high risk for influenza-associated complications during the 2013-14 influenza season. Clin Infect Dis. 2015.
28. Nelson RE, Stockmann C, Hersh AL, Pavia AT, Korgenksi K, Daly JA, Couturier MR, Ampofo K, Thorell EA, Doby EH, et al. Economic analysis of rapid and sensitive polymerase chain reaction testing in the emergency department for influenza infections in children. Pediatr Infect Dis J. 2015;34(6):577-82.
29. Nicholson KG, Abrams KR, Batham S, Medina MJ, Warren FC, Barer M, Bermingham A, Clark TW, Latimer N, Fraser M, et al. Randomised controlled trial and health economic evaluation of the impact of diagnostic testing for influenza, respiratory syncytial virus and Streptococcus pneumoniae infection on the management of acute admissions in the elderly and high-risk 18- to 64-year-olds. Health Technol Assess. 2014;18(36):1-274. vii-viii.